Pfizer says COVID-19 pill near 90 percent effective in final analysis

December 14th, 20210 On Tuesday, Pfizer Inc. said final analysis of its antiviral COVID-19 pill still showed near 90 percent efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus. Last month the U.S. drugmaker...